TB-CRE Symposium held at the Centenary Institute
5 June, 2023 
An infectious disease, tuberculosis (TB) is responsible for approximately 1.6 million deaths every year. However, it is a preventable and, in most cases, treatable disease.
Opened by Professor Warwick Britton AO, Head of the Tuberculosis Research Program at the Centenary Institute and Chief Investigator of the TB-CRE, the symposium featured talks from over 25 TB specialists.
Topics included TB treatments, disease prevention and TB vaccine research, as well as the latest information on TB control programs taking place in Indonesia, Vietnam and Kiribati.
“Over 10 million people develop TB each year which brings with it broad health, societal and economic implications,” said Professor Britton.
“Elimination of this devastating disease will only be achieved with research informing evidence-based interventions and strategies, driving effective and targeted approaches in impacted communities.”
A highlight of the symposium was a keynote talk from Professor Pete Dodd, University of Sheffield, UK, who spoke about the critical role of modelling in estimating global TB burden.
Moreover, Professor Philip Hill, University of Otago, New Zealand, delivered a special guest lecture on integrating public health frameworks and research tools for breakthroughs in TB control.
Other areas explored during the symposium included TB treatment and digital support; TB biomarker discovery and testing; and better understanding TB epidemiology.
The TB-CRE conducts world-class TB research and is focused on improving TB control in Australia and the Asia-Pacific region. The Centenary Institute is an affiliate of the TB-CRE.
